
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. (HOWL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HOWL · as of Jun 8, 2026
Key Statistics
Explore Werewolf Therapeutics, Inc. Data
howl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 100.0%
The HOWL analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $1.00, representing +161.85% upside from the current price of $0.38.
Competitors & Peers
howl competitorsStock Performance
Full HistoryAbout Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the…
what is werewolf therapeutics, inc. · howl stock overview · werewolf therapeutics, inc. company profile · who is werewolf therapeutics, inc. ceo · howl NASDAQ · werewolf therapeutics, inc. headquarters · werewolf therapeutics, inc. business segments
About Stock Overview & Key Data
Werewolf Therapeutics, Inc. (HOWL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 30, 2021. As of the latest trading session, HOWL stock price is $0.38, with a market capitalization of $18.6M. The stock has returned -72.91% over the past 12 months and -39.72% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Werewolf Therapeutics, Inc. stock is Buy, with an average 12-month price target of $1.00. In fiscal year 2025, Werewolf Therapeutics, Inc. reported revenue of — and net income of -$60.8M. For detailed data — including Werewolf Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Werewolf Therapeutics, Inc. (HOWL) stock price is $0.38. The stock is traded on NASDAQ under the ticker symbol HOWL. The 52-week range is $0.37 – $2.38.